As the COVID-19 economic war continues, the media seem to have taken their position on potential treatments. We have previously highlighted a potential botanical extract COVID-19 treatment that prevents key viruses from correctly forming their protective “envelope.” Initial results against COVID-19 showed a dramatic 20,000-fold reduction in viral infectivity within 24 hours, with minimal side effects. The compound has already met FDA Phase I and II safety studies with reputable institutions, but it appears testing in a supervised hospital setting has stalled. Normally the media would celebrate a potential COVID-19 breakthrough treatment, but this is different. Andrew Whitney, vice chairman of Phoenix Biotechnology, joins the Economic War Room to share the real data.
Economic War Room
Why Patriotic Investing Critical to America’s Survival with Guest (Steven Kwast) EP 100